We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

145 hedge funds and large institutions have $1.53B invested in Lexicon Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 38 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

219% more call options, than puts

Call options by funds: $7.88M | Put options by funds: $2.47M

106.32% more ownership

Funds ownership: 0% → 106.32% (+106%)

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

32% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 38

2% more funds holding

Funds holding: 142 → 145 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

23% less capital invested

Capital invested by funds: $2B → $1.53B (-$468M)

Holders
145
Holders Change
+3
Holders Change %
+2.11%
% of All Funds
3.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
50
Reduced
38
Closed
20
Calls
$7.88M
Puts
$2.47M
Net Calls
+$5.41M
Net Calls Change
-$8.08M

Top Buyers

1
EAM
Eagle Asset Management
Florida
+$18.3M
2
BFA
BlackRock Fund Advisors
California
+$8.16M
3
KCM
Kingdon Capital Management
New York
+$6.54M
4
State Street
State Street
Massachusetts
+$3.74M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.72M

Top Sellers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$17.1M
2
UBS AM
UBS AM
Illinois
-$10.8M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.29M
4
BM
Bridger Management
New York
-$6.09M
5
Two Sigma Investments
Two Sigma Investments
New York
-$5.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
151
HBK Investments
Texas
– -$1.26M -69,900 Closed
Prudential Financial
152
Prudential Financial
New Jersey
– -$895K -49,533 Closed
CIP
153
Convergence Investment Partners
Florida
– -$818K -45,279 Closed
TAM
154
Tocqueville Asset Management
New York
– -$452K -25,000 Closed
CSS
155
Cubist Systematic Strategies
Connecticut
– -$312K -17,292 Closed
IA
156
IFP Advisors
Florida
– -$229K -14,252 -100%
KIA
157
Kopp Investment Advisors
Minnesota
– -$207K -11,435 Closed
FAAS
158
First Allied Advisory Services
California
– -$202K -11,200 Closed
Squarepoint
159
Squarepoint
New York
– -$195K -10,800 Closed
Acadian Asset Management
160
Acadian Asset Management
Massachusetts
– -$88K -4,886 Closed
Federated Hermes
161
Federated Hermes
Pennsylvania
– -$78K -4,294 Closed
HNB
162
Huntington National Bank
Ohio
– -$9K -503 Closed
GI
163
Gradient Investments
Minnesota
– -$1K -50 Closed
US Bancorp
164
US Bancorp
Minnesota
– +$465 +29 New
3 4 5 6
7

LXRX Hedge Fund Activity: Q4 2016 in Review

145 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q4 2016, worth a combined $1.53B — down 23% from $2B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new LXRX positions and 20 closed out — a net gain of 7 holders — while 50 added to existing stakes and 38 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $18.3M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $17.1M sold.

  • 145 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q4 2016, up from 142 in Q3 2016.
  • Funds reported $1.53B of Lexicon Pharmaceuticals stock for Q4 2016, down 23% quarter-over-quarter.
  • 27 funds opened new Lexicon Pharmaceuticals positions in Q4 2016 and 20 closed out, a net change of +7 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q4 2016 was Eagle Asset Management, an estimated $18.3M added.
  • The largest Lexicon Pharmaceuticals seller in Q4 2016 was Arrowstreet Capital, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2016.